Wealthfront (WLTH) CEO outlines IPO-related stock sales and RSU activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Wealthfront Corp.'s CEO, president and director reported extensive equity activity in the company’s common stock. On December 11, 2025, multiple restricted stock unit awards and stock options were exercised and settled into shares, with many awards’ performance conditions satisfied in connection with the IPO.
The reporting person had 1,528,003 shares withheld at $14 per share to cover tax obligations from RSU settlements, then sold 765,154 shares at $14 as part of the issuer’s secondary offering in conjunction with its initial public offering. Additional option exercises added 220,000, 242,000 and 162,784 shares at exercise prices of $2.45, $1.67 and $1.50, leaving 1,481,051 shares held directly after the transactions and 153,503 shares held indirectly through a spouse, who also exercised and sold shares on the same date.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 860,570 shares ($12,047,980)
Net Sell
36 txns
Insider
Fortunato David
Role
CEO and President
Sold
860,570 shs ($12.05M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 95,880 | $0.00 | -- |
| Exercise | Restricted Stock Units | 383,519 | $0.00 | -- |
| Exercise | Restricted Stock Units | 599,200 | $0.00 | -- |
| Exercise | Restricted Stock Units | 764,625 | $0.00 | -- |
| Exercise | Restricted Stock Units | 253,521 | $0.00 | -- |
| Exercise | Restricted Stock Units | 475,087 | $0.00 | -- |
| Exercise | Restricted Stock Units | 176,560 | $0.00 | -- |
| Exercise | Restricted Stock Units | 119,062 | $0.00 | -- |
| Exercise | Restricted Stock Units | 141,600 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 220,000 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 242,000 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 162,784 | $0.00 | -- |
| Exercise | Restricted Stock Units | 143,000 | $0.00 | -- |
| Exercise | Restricted Stock Units | 35,919 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 45,000 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 25,000 | $0.00 | -- |
| Exercise | Common Stock | 95,880 | $0.00 | -- |
| Exercise | Common Stock | 383,519 | $0.00 | -- |
| Exercise | Common Stock | 599,200 | $0.00 | -- |
| Exercise | Common Stock | 764,625 | $0.00 | -- |
| Exercise | Common Stock | 253,521 | $0.00 | -- |
| Exercise | Common Stock | 475,087 | $0.00 | -- |
| Exercise | Common Stock | 176,560 | $0.00 | -- |
| Exercise | Common Stock | 119,062 | $0.00 | -- |
| Exercise | Common Stock | 141,600 | $0.00 | -- |
| Tax Withholding | Common Stock | 1,528,003 | $14.00 | $21.39M |
| Exercise | Common Stock | 220,000 | $2.45 | $539K |
| Exercise | Common Stock | 242,000 | $1.67 | $404K |
| Exercise | Common Stock | 162,784 | $1.50 | $244K |
| Sale | Common Stock | 765,154 | $14.00 | $10.71M |
| Exercise | Common Stock | 143,000 | $0.00 | -- |
| Exercise | Common Stock | 35,919 | $0.00 | -- |
| Exercise | Common Stock | 45,000 | $2.45 | $110K |
| Exercise | Common Stock | 25,000 | $2.67 | $67K |
| Sale | Common Stock | 95,416 | $14.00 | $1.34M |
| Grant/Award | Restricted Stock Units | 141,600 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units — 0 shares (Direct);
Stock Option (Right to Buy) — 0 shares (Direct);
Restricted Stock Units — 0 shares (Indirect, By Spouse);
Stock Option (Right to Buy) — 0 shares (Indirect, By Spouse);
Common Stock — 236,250 shares (Direct);
Common Stock — 143,000 shares (Indirect, By Spouse)
Footnotes (1)
- The transaction represents the number of shares of Common Stock withheld by the Issuer to satisfy tax withholding liabilities in connection with the net settlement of restricted stock units. The reported sale transaction was undertaken as part of the Issuer's secondary offering, which occurred in conjunction with its initial public offering ("IPO"). The reported securities are directly held by the reporting person's spouse. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the IPO, and the transaction is reported herein pursuant to Rule 16a-2(a). This restricted stock unit award represents an equity security previously reported on the reporting person's Form 3, which was acquired through an exempt transaction with the Issuer. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO and a service-based vesting requirement which was deemed satisfied as of the grant date, July 14, 2025. The entire award was settled for shares of the Issuer's Common Stock in connection with the IPO. These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested as to 1/8 of the total award quarterly on the fifteenth calendar day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on March 15, 2023. The award was fully time-vested as of December 15, 2024, and the entire award was settled for shares of the Issuer's Common Stock in connection with the IPO. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO and a service-based vesting requirement which was deemed satisfied as of the grant date, November 22, 2022. The entire award was settled for shares of the Issuer's Common Stock in connection with the IPO. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO and a service-based vesting requirement which was deemed satisfied as of the grant date, January 25, 2023. The entire award was settled for shares of the Issuer's Common Stock in connection with the IPO. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested or vests as to 1/16 of the total award quarterly on the fifteenth calendar day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on June 15, 2023. Time-vested portions of the award were settled for shares of the Issuer's Common Stock in connection with the IPO. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO and a service-based vesting requirement which was deemed satisfied as of the grant date, August 4, 2023. The entire award was settled for shares of the Issuer's Common Stock in connection with the IPO. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested as to 1/16 of the total award quarterly on the fifteenth calendar day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on June 15, 2024. Time-vested portions of the award were settled for shares of the Issuer's Common Stock in connection with the IPO. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO and a service-based vesting requirement which was deemed satisfied as of the grant date, October 21, 2024. The entire award was settled for shares of the Issuer's Common Stock in connection with the IPO. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested as to 1/16 of the total award quarterly on the fifteenth calendar day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on June 15, 2025. Time-vested portions of the award were settled for shares of the Issuer's Common Stock in connection with the IPO. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO and a service-based vesting requirement which was deemed satisfied as of the grant date, July 14, 2025. The entire award was settled for shares of the Issuer's Common Stock in connection with the IPO. The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on May 23, 2020. The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on May 17, 2021. The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on December 27, 2021. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested as to 1/8 of the total award quarterly on the fifteenth calendar day of March, June, September, and December, subject to the reporting person's spouse's continued service to the Issuer on each vesting date, with the first tranche time-vested on March 15, 2023. Although the award ceased vesting following the reporting person's spouse's separation from service to the issuer, the entire outstanding portion of the award was settled for shares of the Issuer's Common Stock in connection with the IPO. The option is fully vested. Pursuant to the terms of the reporting person's spouse's award agreement with the Issuer, the award became fully vested on August 15, 2020. The option is fully vested. Pursuant to the terms of the reporting person's spouse's award agreement with the Issuer, the award became fully vested on October 24, 2020.
FAQ
What insider transactions did Wealthfront (WLTH) report on December 11, 2025?
The CEO, president and director of Wealthfront Corp. reported multiple equity transactions on December 11, 2025, including restricted stock unit settlements, stock option exercises, tax-withholding share transfers and open market sales of common stock by both the reporting person and the reporting person’s spouse.
What stock options did the Wealthfront CEO exercise and at what prices?
On December 11, 2025, the reporting person exercised stock options covering 220,000 shares at an exercise price of $2.45, 242,000 shares at $1.67, and 162,784 shares at $1.50 per share. The filing notes that these options had previously become fully vested under the terms of the award agreements.
How were restricted stock units structured around Wealthfront’s IPO?
The filing explains that each restricted stock unit represents a contingent right to receive one share of Wealthfront common stock. Many awards were subject to performance-based vesting conditions that were satisfied in connection with the IPO, combined with service-based vesting schedules. Several awards became fully time-vested by dates such as December 15, 2024, and were then settled into shares in connection with the IPO.
What transactions were reported for the Wealthfront CEO’s spouse?
The reporting person’s spouse directly held securities and, on December 11, 2025, had restricted stock units settled into shares at $0 and exercised stock options covering 45,000 shares at $2.45 and 25,000 shares at $2.67 per share. The spouse also sold 95,416 shares at $14 per share as part of the issuer’s secondary offering, ending with 153,503 shares held indirectly for the reporting person.